Exenatide once weekly: clinical outcomes and patient satisfaction

Exenatide once weekly: clinical outcomes and patient satisfaction

Biju Jose1, Abd A Tahrani1,2, Milan K Piya1,2, Anthony H Barnett1,21Department of Diabetes and Endocrinology, Heart of England NHS Foundation Trust, Birmingham, UK; 2School of Clinical and Experimental Medicine, University of Birmingham, Birmingham, UKBackground: Type 2 diabetes mellitus (T2DM) is a...

Full description

Bibliographic Details
Main Authors:	Biju Jose1, Abd A Tahrani, Milan K Piya, et al
Format:	Article
Language:	English
Published:	Dove Medical Press 2010-08-01
Series:	Patient Preference and Adherence
Online Access:	http://www.dovepress.com/exenatide-once-weekly-clinical-outcomes-and-patient-satisfaction-a5065

Similar Items

Emerging utility of once-weekly exenatide in patients with type 2 diabetes
by: Goud A, et al.
Published: (2015-10-01)

Efficacy and safety of once‐weekly exenatide after switching from twice‐daily exenatide in patients with type 2 diabetes
by: Yuusuke Watanabe, et al.
Published: (2020-03-01)

Exenatide Once Weekly for Management of Type 2 Diabetes: A Review
by: Inaishi J, et al.
Published: (2022-02-01)

Exenatide extended-release: a once weekly treatment for patients with type 2 diabetes
by: Mann KV, et al.
Published: (2014-06-01)

Effect of race on cardiometabolic responses to once-weekly exenatide: insights from the Exenatide Study of Cardiovascular Event Lowering (EXSCEL)
by: Timothy M. E. Davis, et al.
Published: (2022-06-01)

Exenatide once-weekly injection for the treatment of type 2 diabetes in Chinese patients: current perspectives
by: Deng W, et al.
Published: (2015-08-01)

Exenatide once weekly for alcohol use disorder investigated in a randomized, placebo-controlled clinical trial
by: Mette Kruse Klausen, et al.
Published: (2022-10-01)

Real-world glycemic outcomes in patients with type 2 diabetes initiating exenatide once weekly and liraglutide once daily: a retrospective cohort study
by: Saunders WB, et al.
Published: (2016-07-01)

Critical appraisal of once-weekly formulation of exenatide in the control of type 2 diabetes mellitus
by: Jason Seewoodhary, et al.
Published: (2010-05-01)

Critical appraisal of once-weekly formulation of exenatide in the control of type 2 diabetes mellitus
by: Seewoodhary J, et al.
Published: (2010-05-01)

Safety and tolerability of exenatide once weekly in patients with type 2 diabetes: an integrated analysis of 4,328 patients
by: MacConell L, et al.
Published: (2015-05-01)

Treatment with exenatide once weekly or twice daily for 30 weeks is associated with changes in several cardiovascular risk markers
by: Chiquette E, et al.
Published: (2012-11-01)

EXSCEL—once-weekly exenatide reduces medical resource utilization in patients with type 2 diabetes mellitus
by: Reed, S, et al.
Published: (2018)

Effect of Once‐Weekly Exenatide on Clinical Outcomes According to Baseline Risk in Patients With Type 2 Diabetes Mellitus: Insights From the EXSCEL Trial
by: Robert J. Mentz, et al.
Published: (2018-10-01)

Exenatide once weekly: sustained improvement in glycemic control and cardiometabolic measures through 3 years
by: MacConell L, et al.
Published: (2013-01-01)

Exenatide once weekly treatment maintained improvements in glycemic control and weight loss over 2 years
by: Pencek Richard, et al.
Published: (2011-04-01)

Health and economic outcomes for exenatide once weekly, insulin, and pioglitazone therapies in the treatment of type 2 diabetes: a simulation analysis
by: Gaebler JA, et al.
Published: (2012-04-01)

The short-term cost-effectiveness of once-daily liraglutide versus once-weekly exenatide for the treatment of type 2 diabetes mellitus in the United States.
by: Bruce Wang, et al.
Published: (2015-01-01)

Lifetime cost-effectiveness simulation of exenatide once-weekly in type 2 diabetes: evidence from the EXSCEL trial
by: Becker, F, et al.
Published: (2018)

Hypothyroidism Could be a Potential Factor to Prolong Subcutaneous Nodules of Exenatide once Weekly: A Case Report
by: Ayako Ito, MD, et al.
Published: (2019-05-01)

The Effects of Exenatide Once Weekly (EXQW) and Exenatide Twice a Day (EXBID) on Beta-Cell Function in Type 2 Diabetes: A Systematic Review and Network Meta-Analysis
by: Jie Wang, et al.
Published: (2019-01-01)

Further improvement in glycemic control after switching from exenatide two times per day to exenatide once-weekly autoinjected suspension in patients with type 2 diabetes: 52-week results from the DURATION-NEO-1 study
by: Carol H Wysham, et al.
Published: (2020-04-01)

Changes in glycemic variability, gastric emptying and vascular endothelial function after switching from twice-daily to once-weekly exenatide in patients with type 2 diabetes: a subpopulation analysis of the twin-exenatide study
by: Jun Inaishi, et al.
Published: (2022-01-01)

Lifetime cost-effectiveness simulation of once-weekly exenatide in type 2 diabetes: a cost-utility analysis based on the EXSCEL trial
by: Becker, F, et al.
Published: (2021)

Exenatide once weekly over 2 years as a potential disease-modifying treatment for Parkinson’s disease: protocol for a multicentre, randomised, double blind, parallel group, placebo controlled, phase 3 trial: The ‘Exenatide-PD3’ study
by: Thomas Foltynie, et al.
Published: (2021-05-01)

Exenatide improves glucocorticoid-induced glucose intolerance in mice
by: Ruiying Zhao, et al.
Published: (2011-01-01)

Comparison of different dosing regimens (once weekly <it>vs</it>. twice weekly, and once weekly <it>vs</it>. once every two weeks) with epoetin delta in patients with chronic kidney disease: a randomized controlled trial
by: Macdougall Iain C
Published: (2007-11-01)

An antiinflammatory actions of exenatide
Published: (2012-12-01)

Exenatide extended-release; clinical trials, patient preference, and economic considerations
by: Doggrell SA
Published: (2013-01-01)

Effectiveness and Tolerability of Once-Weekly GLP-1 Receptor Agonists in Clinical Practice: A Focus on Switching Between Once-Weekly Molecules in Type 2 Diabetes
by: Giulia Di Dalmazi, et al.
Published: (2022-07-01)

Binge eating disorder and night eating syndrome in adults with type 2 diabetes: a systematic review
by: Sally Abbott, et al.
Published: (2018-11-01)

Long-acting preparations of exenatide
by: Cai Y, et al.
Published: (2013-09-01)

Effect of once weekly oral levothyroxine therapy
by: Andrea del Toro-Diez, et al.
Published: (2021-07-01)

Real-world use of once-weekly semaglutide in patients with type 2 diabetes at an outpatient clinic in Spain
by: Maria Dolores Garcia de Lucas, et al.
Published: (2022-09-01)

Comparative clinical utility of once-weekly subcutaneous abatacept in the management of rheumatoid arthritis
by: Rakieh C, et al.
Published: (2014-04-01)

Pharmalogical effects and results of clinical trials of the first incretinomimetic exenatide
by: Alexander Sergeevich Ametov, et al.
Published: (2011-09-01)

Impact of patient background factors on the treatment efficacy of once-weekly teriparatide
by: Fumitoshi Omura
Published: (2019-06-01)

Adherence to GLP-1 receptor agonist therapy administered by once-daily or once-weekly injection in patients with type 2 diabetes in Germany
by: Qiao Q, et al.
Published: (2016-06-01)

The efficacy of metformin and exenatide in Polycystic Ovary Syndrome (PCOS) patients
by: Kesavan, Sanggeeta, et al.
Published: (2023)

Once-a-week versus once-every-3-weeks cisplatin in patients receiving chemoradiation for locally advanced head-and-neck cancer: A survey of practice in India
by: Gautam Goyal, et al.
Published: (2018-01-01)